XML 62 R55.htm IDEA: XBRL DOCUMENT v3.25.2
Segment Information - Schedule of Significant Expense Categories Provided to CODM (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Segment Reporting Information [Line Items]        
Revenues $ 316 $ 468 $ 697 $ 1,016
Less:        
Cost of revenues 170 124 276 343
R&D costs 2,954 1,722 5,469 3,941
G&A costs 2,589 2,122 5,530 4,322
Net loss (5,028) (3,413) (10,039) (7,471)
Reportable Segment [Member]        
Segment Reporting Information [Line Items]        
Revenues [1] 316 468 697 1,016
Less:        
Cost of revenues 170 124 276 343
R&D costs [2] 739 545 1,225 1,374
G&A costs [3] 1,387 1,233 2,788 2,648
Personnel costs [4] 2,961 1,727 5,983 3,565
Other segment items [5] 87 252 464 557
Net loss $ (5,028) $ (3,413) $ (10,039) $ (7,471)
[1] Includes Contract Manufacturing and Clinical Trial revenue
[2] Includes Clinical Development, Research & Discovery, CMC
[3] Includes Executive, Finance, Legal, Business Operations
[4] Includes compensation, benefits and equity-based compensation
[5] Includes depreciation and amortization, (interest income) and other specific charges